| 778468 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex |
2021-12-01 |
10.1186/s13046-021-02182-4 |
Fang Wanxia, Che Xiaofang, Li Guohui, Wang Anhui, Wang Yizhe, Shi Xiaonan, Hou Kezuo, Zhang Xiaojie, Qu Xiujuan, Liu Yunpeng |
| 778467 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression |
2021-12-01 |
10.1186/s13046-021-02181-5 |
Zhang Dongmei, Lin Jingrong, Chao Yulin, Zhang Lu, Jin Lei, Li Na, He Ruiping, Ma Binbin, Zhao Wenzhi, Han Chuanchun |
| 778466 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance |
2021-12-01 |
10.1186/s13046-021-02165-5 |
Feng Chenchen, Li Yuqing, Li Kunping, Lyu Yinfeng, Zhu Wenhui, Jiang Haowen, Wen Hui |
| 778465 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics |
2021-12-01 |
10.1186/s13046-021-02193-1 |
Cuciniello Rossana, Filosa Stefania, Crispi Stefania |
| 778464 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas |
2021-12-01 |
10.1186/s13046-021-02161-9 |
Mudassar Faiqa, Shen Han, O’Neill Geraldine, Hau Eric |
| 778463 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy |
2021-12-01 |
10.1186/s13046-021-02192-2 |
Bongiorno Roberta, Colombo Mario Paolo, Lecis Daniele |
| 778462 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells |
2021-12-01 |
10.1186/s13046-021-02183-3 |
Li Weidong, Dong Xuesong, He Changjun, Tan Gang, Li Ziyi, Zhai Bo, Feng Jing, Jiang Xian, Liu Chang, Jiang Hongchi, Sun Xueying |
| 778461 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway |
2021-12-01 |
10.1186/s13046-021-02179-z |
Jiang Ning, Liao Yihao, Wang Miaomiao, Wang Youzhi, Wang Keke, Guo Jianing, Wu Peikang, Zhong Boqiang, Guo Tao, Wu Changli |
| 778460 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Correction to: YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway |
2021-12-01 |
10.1186/s13046-021-02189-x |
Zhang Jian, Wen Xin, Ren Xian-Yue, Li Ying-Qin, Tang Xin-Ran, Wang Ya-Qin, He Qing-Mei, Yang Xiao-Jing, Sun Ying, Liu Na, Ma Jun |
| 778459 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Retraction Note: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance |
2021-12-01 |
10.1186/s13046-021-02204-1 |
Zhou Shan, Lu Jinping, Li Yuejin, Chen Chan, Cai Yongqiang, Tan Gongjun, Peng Zhengke, Zhang Zhenlin, Dong Zigang, Kang Tiebang, Tang Faqing |
